Links between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?
Citations Over TimeTop 10% of 2008 papers
Abstract
A key phenotype associated with type 2 diabetes in humans is impaired mitochondrial oxidative metabolism in skeletal muscle, a pattern potentially contributing to increased lipid accumulation and impaired metabolic flexibility-in turn, central features of both insulin resistance and diabetes. Since thyroid hormone regulates mitochondrial gene expression and function in skeletal muscle, reductions in T3-mediated transcription may contribute to diabetes-related impairments in oxidative metabolism. We review the evidence for relationships between thyroid hormone action and diabetes risk, and discuss potential mechanisms linking intracellular thyroid hormone availability, thyroid receptor action, and the transcriptional coactivator PGC1 in regulating oxidative metabolism.
Related Papers
- → CerS1-Derived C18:0 Ceramide in Skeletal Muscle Promotes Obesity-Induced Insulin Resistance(2019)193 cited
- → A role for helix 3of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone(1998)144 cited
- → Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines(2008)20 cited
- → Jab1 is a T2-dependent coactivator or a T3-dependent corepressor of TRB1-mediated gene regulation(2017)6 cited
- → A method for efficient production of recombinant thyroid hormone receptors reveals that receptor homodimer–DNA binding is enhanced by the coactivator TIF2(2005)13 cited